These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4179866)

  • 1. Blood-potassium in patients undergoing haemodialysis.
    Goldner MG; Bleicher SJ; Spergel G
    Lancet; 1969 Mar; 1(7594):575-6. PubMed ID: 4179866
    [No Abstract]   [Full Text] [Related]  

  • 2. Blood-potassium in patients undergoing haemodialysis.
    Seedat YK; Berlyne GM; Laethem LV
    Lancet; 1969 Feb; 1(7590):373. PubMed ID: 4179389
    [No Abstract]   [Full Text] [Related]  

  • 3. Exchangeable potassium study in patients undergoing chronic haemodialysis.
    Seedat YK
    Br Med J; 1969 May; 2(5653):344-5. PubMed ID: 5768459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of potassium on blood-sugar and plasma-insulin levels in patients undergoing peritoneal dialysis and haemodialysis.
    Seedat YK
    Lancet; 1968 Nov; 2(7579):1167-9. PubMed ID: 4176948
    [No Abstract]   [Full Text] [Related]  

  • 5. Potassium balance and acid-base changes in patients undergoing regular haemodialysis therapy.
    Morgan AG; Burkinshaw L; Robinson PJ; Rosen SM
    Br Med J; 1970 Mar; 1(5699):779-83. PubMed ID: 5443380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Plasma aldosterone during haemodialysis in patients with terminal renal failure].
    Schnurr E; Küppers H; Wiesen K; Grabensee B
    Dtsch Med Wochenschr; 1976 Jul; 101(30):1120, 1125-8. PubMed ID: 1278056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The technological progress in haemodialysis: potassium profiling].
    Kes P; Racki S; Basić-Jukić N; Ratković-Gusić I
    Acta Med Croatica; 2008; 62 Suppl 1():12-6. PubMed ID: 18578327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of dialysis on the carbohydrate intolerance of chronic renal failure.
    Spitz I; Rubenstein AH; Bersohn I; Lawrence AM; Kirsteins L
    Horm Metab Res; 1970 Mar; 2(2):86-93. PubMed ID: 4939148
    [No Abstract]   [Full Text] [Related]  

  • 9. Electroconvulsion therapy and the haemodialysis dependent patient.
    MacEvilly M; Riordan D; Ryan JP; Unwin AR
    Ir J Med Sci; 1983 Oct; 152(10):392-3. PubMed ID: 6642958
    [No Abstract]   [Full Text] [Related]  

  • 10. Exchangeable potassium content and distribution in normal subjects and uraemic patients on chronic haemodialysis.
    Rettori V; Gral T; Massry SG; Villamil MF
    Clin Sci; 1972 Jun; 42(6):673-84. PubMed ID: 5033806
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasma aldosterone during haemodialysis in patients with terminal renal failure.
    Vetter W; Záruba K; Armbuster H; Strebel U; Beckerhoff R; Siegenthaler W
    Proc Eur Dial Transplant Assoc; 1973; 10(0):332-41. PubMed ID: 4370265
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma potassium in patients with terminal renal failure during and after haemodialysis; relationship with dialytic potassium removal and total body potassium.
    Blumberg A; Roser HW; Zehnder C; Müller-Brand J
    Nephrol Dial Transplant; 1997 Aug; 12(8):1629-34. PubMed ID: 9269640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Disorders of carbohydrate metabolism in patients with renal failure].
    Rutkowski B; Kicińska M
    Pol Tyg Lek; 1975 Sep; 30(38):1587-90. PubMed ID: 1101238
    [No Abstract]   [Full Text] [Related]  

  • 14. [Carbohydrate-lipid metabolism in chronic renal failure. Considerations on some blood lipid parameters examined during conservative and dialysis treatment].
    Zuliani U; Novarini A; Bandini L; Borghi L; Canali M; Caronna S; Perinotto P
    Minerva Nefrol; 1976; 23(6):423-34. PubMed ID: 1012614
    [No Abstract]   [Full Text] [Related]  

  • 15. Impaired extrarenal disposal of an acute oral potassium load in patients with endstage renal disease on chronic hemodialysis.
    Fernandez J; Oster JR; Perez GO
    Miner Electrolyte Metab; 1986; 12(2):125-9. PubMed ID: 3960016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypercalcaemia from calcium ion-exchange resin in patients on regular haemodialysis.
    Papadimitriou M; Gingell JC; Chisholm GD
    Lancet; 1968 Nov; 2(7575):948-50. PubMed ID: 4176266
    [No Abstract]   [Full Text] [Related]  

  • 17. Dietary potassium and laxatives as regulators of colonic potassium secretion in end-stage renal disease.
    Mathialahan T; Sandle GI
    Nephrol Dial Transplant; 2003 Feb; 18(2):341-7. PubMed ID: 12543890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemodialysis and haemofiltration on cardiopulmonary bypass.
    Hakim M; Wheeldon D; Bethune DW; Milstein BB; English TA; Wallwork J
    Thorax; 1985 Feb; 40(2):101-6. PubMed ID: 3975860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a simultaneous potassium and carbohydrate load on extrarenal K homeostasis in end-stage renal failure.
    Alvo M; Krsulovic P; Fernández V; Espinoza AM; Escobar M; Marusic ET
    Nephron; 1989; 53(2):133-7. PubMed ID: 2682302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of fludrocortisone acetate on reducing serum potassium levels in patients with end-stage renal disease undergoing haemodialysis.
    Kim DM; Chung JH; Yoon SH; Kim HL
    Nephrol Dial Transplant; 2007 Nov; 22(11):3273-6. PubMed ID: 17616536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.